Skip to content

TECNIS IOL DIU300 (REF DIU300U175)Recalls & reported problems

Johnson & Johnson Surgical Vision, Inc. · TEC EYHANCE TOR II SMPLCTY 17.5D CYL3.00 · Class 3 · Implant

All models of TECNIS IOL (1344)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 05050474747678), received between Jul 13, 2021 and Jul 13, 2021 — classified as 1 injury.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1

Patient problems

  • Visual Impairment1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryJul 13, 2021Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT AN INTRAOCULAR LENS (IOL) WAS EXPLANTED FROM THE PATIENT'S LEFT EYE DUE TO A REFRACTIVE ERROR. ONLY PART OF THE LENS WAS ABLE TO BE SALVAGED. ADDITIONAL INFORMATION WAS PROVIDED AND REPORTED THE PATIENT HAD POST OPERATIVE(OP) HYPEROPIC SURPRISE SINCE DAY 1 POST-OP. THERE WAS NO PATIENT INJURY AND NO REPORT OF ANY MEDICAL OR SURGICAL INTERVENTION REQUIRED. ANOTHER JOHNSON & JOHNSON LENS DIU300 19.5 (SAME MODEL AND HIGHER DIOPTER) WAS IMPLANTED AS A REPLACEMENT. THE PATIENT'S VISION OUTCOME POST-OP PERIOD IS STILL BLURRY. NO FURTHER INFORMATION IS AVAILABLE.

    Patient problems: Visual Impairment

    MAUDE report 12164334 ↗

Other LENS, INTRAOCULAR, TORIC OPTICS devices

All LENS, INTRAOCULAR, TORIC OPTICS devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page